Secondaries announced 5.5.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aldeyra Therapeutics Inc. Symbol: ALDX Price: Last trade $9.27 Trade Date: 5/8 Shares: 3 million Underwriter(s) Cowen & Co., Canaccord Genuity[…]